Cite
[Successful VEP-IFN-alpha therapy in a case of non-secretory plasma cell leukemia (BJ-kappa type)]
MLA
Y, Masaki, et al. “[Successful VEP-IFN-Alpha Therapy in a Case of Non-Secretory Plasma Cell Leukemia (BJ-Kappa Type)].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, vol. 35, no. 6, June 1994. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........4c27428f05322ce99224efa4669f3ac4&authtype=sso&custid=ns315887.
APA
Y, M., S, S., S, T., M, F., R, Y., T, A., Y, H., S, S., S, K., & T, T. (1994). [Successful VEP-IFN-alpha therapy in a case of non-secretory plasma cell leukemia (BJ-kappa type)]. [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, 35(6).
Chicago
Y, Masaki, Shimizu S, Takeshita S, Fukutoku M, Yoshioka R, Arai T, Hirose Y, Sugai S, Konda S, and Takiguti T. 1994. “[Successful VEP-IFN-Alpha Therapy in a Case of Non-Secretory Plasma Cell Leukemia (BJ-Kappa Type)].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology 35 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........4c27428f05322ce99224efa4669f3ac4&authtype=sso&custid=ns315887.